Management of Upper Respiratory Infection with Secondary Bacterial Infection in High-Risk Patients

Patient Monitoring and Care

This patient is at higher risk for opportunistic infections and treatment failure due to lupus-related immunosuppression 1
Monitor blood glucose closely as infection can destabilize glycemic control, and ensure adequate hydration while avoiding fluid overload given underlying pulmonary fibrosis 2

Never use azithromycin as monotherapy if non-tuberculous mycobacterial (NTM) infection is suspected, as this can lead to macrolide resistance 3
A 2-week washout period may be required if NTM evaluation is needed, due to intracellular accumulation of azithromycin 3
If the patient develops severe symptoms such as respiratory rate >30 breaths/min, oxygen saturation decline, systolic BP <90 mmHg, altered mental status, or signs of sepsis, hospitalization and IV antibiotics should be considered 8

Complete the full 5-day course of azithromycin (500 mg on day 1, then 250 mg daily for days 2-5), and do not extend to 7-10 days unless pneumonia is confirmed 8
Clinical response should be evident within 2-3 days of initiating antibiotic therapy, with fever resolution as the primary marker, and schedule follow-up within 7-10 days to ensure complete resolution and assess for any complications 8, 1